| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |